{"id":51197,"date":"2022-11-23T16:02:44","date_gmt":"2022-11-23T15:02:44","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/clinical-laboratory-service-global-market-report-2022-growing-prevalence-of-target-diseases-coupled-with-rising-demand-for-early-disease-diagnostic-tests-fuels-sector-researchandmarkets-com\/"},"modified":"2022-11-23T16:02:44","modified_gmt":"2022-11-23T15:02:44","slug":"clinical-laboratory-service-global-market-report-2022-growing-prevalence-of-target-diseases-coupled-with-rising-demand-for-early-disease-diagnostic-tests-fuels-sector-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/clinical-laboratory-service-global-market-report-2022-growing-prevalence-of-target-diseases-coupled-with-rising-demand-for-early-disease-diagnostic-tests-fuels-sector-researchandmarkets-com\/","title":{"rendered":"Clinical Laboratory Service Global Market Report 2022: Growing Prevalence Of Target Diseases Coupled With Rising Demand For Early Disease Diagnostic Tests Fuels Sector – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Clinical Laboratory Service Market Size, Share & Trends Analysis Report by Test Type (Human & Tumor Genetics, Clinical Chemistry), by Service Provider (Standalone, Hospital-based Labs), by Application, and Segment Forecasts, 2022-2030”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe global clinical laboratory service market size is expected to reach USD 280.67 billion by 2030, registering a CAGR of 3.7% from 2022 to 2030. The growth of the industry can be attributed to the increasing prevalence of the geriatric population, which, in turn, is propelling the demand for early disease diagnosis. The growing prevalence of target diseases, such as diabetes and Cardiovascular Diseases (CVDs), is a high impact-rendering driver for industry growth over the forecast period. Cardiovascular disease is the leading cause of death globally. The presence of unmet medical needs pertaining to disease management and the subsequent increase in patient awareness in more regions are expected to boost the demand for clinical laboratory testing.\n<\/p>\n

\nImprovements in laboratory testing technology through breakthroughs and incremental advances are high-impact-rendering drivers for industry growth. Market firms are engaged in introducing new services to serve the unmet demand of patients. For instance, in May 2022, Hamilton County entered into a partnership with Ethos Laboratories for the launch of no-cost COVID-19 testing sites. In July 2022, Mayo Clinic laboratories launched monkey pox tests to increase availability and accessibility to a wider target population. Moreover, in January 2022, Quest Diagnostics launched COVID-19 rapid antigen tests available through QuestDirect in collaboration with eMed to provide access to testing for COVID-19 at home. The pandemic affected millions of people globally. According to the CDC and WHO, the standard for diagnosis of COVID-19 is RT-PCR for samples from the respiratory tract.\n<\/p>\n

\nThe adoption of PCR technology for the diagnosis of COVID-19 and the genetic sequencing of the virus for the development of a cure is driving the industry. Due to this pandemic, there is an increase in the approval of tests for the diagnosis of the novel coronavirus, with most of these tests approved under Emergency Use Authorization (EUA) by federal agencies. Furthermore, the industry operates through different sales channels – laboratories and hospitals. The presence of prominent players in various regions is expected to drive the industry. For instance, in February 2022, Labcorp entered into a comprehensive partnership with Ascension. Through this collaboration, Labcorp will handle Ascension’s hospital-based labs situated in ten states for buying assets for its outreach laboratory business.\n<\/p>\n

\nClinical Laboratory Service Market Report Highlights<\/strong>\n<\/p>\n